
Siren Biotechnology
Operator of a biotech company intended to provide a gene therapy for a variety of cancer treatments. The company's therapy integrates adeno-associated virus-based gene therapy with immunotherapy, deli...
Valuation
$0
Share Price
N/A
Total Raised
$25.6M
Last Round
N/A